2.
stock-based
compensation
The
Company accounts for stock-based compensation based on the fair value of the stock or stock-based instrument on the date of grant.
In
January 2017, the Company granted 59,395 restricted stock units (“RSUs”) to its board of directors as partial compensation
for the 2017 year. On January 1, 2016, the Company granted 53,882 RSUs to its board of directors as partial compensation for the
2016 year. RSUs vest quarterly on a straight-line basis over a one-year period. The Company’s net income (loss) for the
nine months ended September 30, 2017 and 2016 includes approximately $517,000 and $564,500, respectively, of noncash compensation
expense related to the RSU grants to the board of directors. This expense is recorded as a component of selling, general and administrative
expenses.
In addition, for the nine months ended
September 30, 2017, the Company granted 5,550 shares of common stock to various employees and approximately $13,300 of compensation
expense is included in selling, general and administrative expenses and approximately $37,500 of compensation expense is included
in cost of sales for this grant.
In
August 2016 and March 2017, the Company granted 98,645 and 73,060 shares of common stock, respectively, to various employees.
In the event that any of these employees voluntarily
terminates their employment prior to certain dates, portions of the shares may be forfeited. In addition, if certain Company performance
criteria are not achieved, portions of these shares may be forfeited. These shares will be expensed during various periods through
March 2021 based upon the service and performance thresholds. For the nine months ended September 30, 2017, approximately $208,800
of compensation expense is included in selling, general and administrative expenses and approximately $44,100 of compensation
expense is included in cost of sales for this grant. In March 2017, 12,330 of the shares granted in August of 2016 were forfeited
because the Company failed to achieve certain performance criteria for the year ended December 31, 2016. In addition, on March
9, 2017, these employees returned 4,525 common shares, valued at approximately $33,000, to pay the employees’ withholding
taxes.
A
summary of the status of the Company’s stock option plans as of September 30, 2017 and changes during the nine months ended
September 30, 2017 is as follows:
|
|
Options
|
|
Weighted
average exercise price
|
|
Weighted
average remaining contractual term (in years)
|
|
Aggregate
intrinsic value
|
Outstanding
|
|
|
|
|
|
|
|
|
at
beginning of period
|
|
|
149,466
|
|
|
$
|
10.43
|
|
|
|
|
|
|
|
|
|
Outstanding
and vested
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
at
end of period
|
|
|
149,466
|
|
|
$
|
10.43
|
|
|
|
0.83
|
|
|
$
|
123,300
|
|
During
the nine months ended September 30, 2017 and September 30, 2016, no stock options were granted or exercised.
NOTES
TO CONDENSED FINANCIAL STATEMENTS
(UNAUDITED
)
3.
Derivative
Instruments and Fair Value
The
Company’s use of derivative instruments has been to hedge interest rates. These derivative contracts are entered into
with a financial institution. The Company does not use derivative instruments for trading purposes and has procedures
in place to monitor and control their use.
We
record these derivative financial instruments on the condensed balance sheets at fair value. For derivative instruments that are
designated and qualify as a cash flow hedge, the effective portion of the gain or loss on the derivative instrument is reported
as a component of other comprehensive income (loss) and reclassified into earnings in the same period or periods during which
the hedged transaction affects earnings.
Any
ineffective portion of the gain or loss on the derivative instrument for a cash flow hedge is recorded in the results of operations
immediately. For derivative instruments not designated as hedging instruments, the gain or loss is recognized in the results of
operations immediately.
In
March 2012, the Company entered into interest rate swaps with the objective of reducing the Company’s exposure to cash
flow volatility arising from interest rate fluctuations associated with certain debt. The notional amount, maturity date, and
currency of these contracts match those of the underlying debt. The Company has designated these interest rate swap contracts
as cash flow hedges. The Company measures ineffectiveness by comparing the cumulative change in the forward contact with the
cumulative change in the hedged item. No material ineffectiveness was recognized in the quarter ended March 31, 2016. The
interest rate swap contract was terminated as of March 24, 2016. The Company paid approximately $4,000 at termination to
settle the swap contract.
In
May 2016, the Company entered into a new interest rate swap with the objective of reducing its exposure to cash flow
volatility arising from interest rate fluctuations associated with certain debt. The notional amount, maturity date, and
currency of this contract match those of the underlying debt. The Company has designated this interest rate swap contract as
a cash flow hedge. The Company measures ineffectiveness by comparing the cumulative change in the forward contact with the
cumulative change in the hedged item. As of September 30, 2017, the Company had a net deferred loss associated with the
interest rate swap of approximately $10,800, which was included in other liabilities.
Fair
Value
At
September 30, 2017 and December 31, 2016, the fair values of cash, accounts receivable, accounts payable and accrued expenses
approximated their carrying values because of the short-term nature of these instruments.
|
|
September
30, 2017
|
|
|
Carrying
Amount
|
|
Fair
Value
|
Debt
|
|
|
|
|
Short-term
borrowings and long-term debt
|
|
$
|
32,768,421
|
|
|
$
|
32,768,421
|
|
|
|
December
31, 2016
|
|
|
Carrying
Amount
|
|
Fair
Value
|
Debt
|
|
|
|
|
Short-term
borrowings and long-term debt
|
|
$
|
32,689,467
|
|
|
$
|
32,689,467
|
|
The
Company estimated the fair value of debt using market quotes and calculations based on market rates.
NOTES
TO CONDENSED FINANCIAL STATEMENTS
(UNAUDITED
)
The
following table presents the fair values of those financial liabilities measured on a recurring basis as of September 30, 2017
and December 31, 2016:
|
|
|
|
Fair
Value Measurements September 30, 2017
|
Description
|
|
Total
|
|
Quoted
Prices in Active Markets for Identical assets
(Level 1)
|
|
Significant
Other Observable Inputs
(Level 2)
|
|
Significant
Unobservable Inputs
(Level 3)
|
Interest
Rate Swap, net
|
|
$
|
10,765
|
|
|
|
—
|
|
|
$
|
10,765
|
|
|
|
—
|
|
Total
|
|
$
|
10,765
|
|
|
|
—
|
|
|
$
|
10,765
|
|
|
|
—
|
|
|
|
|
|
Fair
Value Measurements December 31, 2016
|
Description
|
|
Total
|
|
Quoted
Prices in Active Markets for Identical assets
(Level 1)
|
|
Significant
Other Observable Inputs
(Level 2)
|
|
Significant
Unobservable Inputs
(Level 3)
|
Interest
Rate Swap, net
|
|
$
|
13,685
|
|
|
|
—
|
|
|
$
|
13,685
|
|
|
|
—
|
|
Total
|
|
$
|
13,685
|
|
|
|
—
|
|
|
$
|
13,685
|
|
|
|
—
|
|
The
fair value of the Company’s interest rate swap was determined by comparing the fixed rate set at the inception of the transaction
to the “replacement swap rate,” which represents the market rate for an offsetting interest rate swap with the same
notional amounts and final maturity date. The market value is then determined by calculating the present value of the interest
differential between the contractual swap and the replacement swap.
NOTES
TO CONDENSED FINANCIAL STATEMENTS
(UNAUDITED)
4.
COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS
Costs
and estimated earnings in excess of billings on uncompleted contracts consist of the following:
|
|
September
30, 2017
|
|
|
U.S.
|
|
|
|
|
|
|
Government
|
|
Commercial
|
|
Total
|
Costs
incurred on uncompleted contracts
|
|
$
|
368,164,864
|
|
|
$
|
171,052,715
|
|
|
$
|
539,217,579
|
|
Estimated
earnings
|
|
|
34,663,617
|
|
|
|
71,877,761
|
|
|
|
106,541,378
|
|
Sub-total
|
|
|
402,828,481
|
|
|
|
242,930,476
|
|
|
|
645,758,957
|
|
Less
billings to date
|
|
|
357,402,993
|
|
|
|
180,391,063
|
|
|
|
537,794,056
|
|
Costs
and estimated earnings in excess of billings on uncompleted contracts
|
|
$
|
45,425,488
|
|
|
$
|
62,539,413
|
|
|
$
|
107,964,901
|
|
|
|
December
31, 2016
|
|
|
U.S.
|
|
|
|
|
|
|
Government
|
|
Commercial
|
|
Total
|
Costs
incurred on uncompleted contracts
|
|
$
|
341,003,461
|
|
|
$
|
153,898,425
|
|
|
$
|
494,901,886
|
|
Estimated
earnings
|
|
|
39,638,231
|
|
|
|
58,346,518
|
|
|
|
97,984,749
|
|
Sub-total
|
|
|
380,641,692
|
|
|
|
212,244,943
|
|
|
|
592,886,635
|
|
Less
billings to date
|
|
|
331,277,942
|
|
|
|
162,145,504
|
|
|
|
493,423,446
|
|
Costs
and estimated earnings in excess of billings on uncompleted contracts
|
|
$
|
49,363,750
|
|
|
$
|
50,099,439
|
|
|
$
|
99,463,189
|
|
The
above amounts are included in the accompanying condensed balance sheets under the following captions at September 30, 2017 and
December 31, 2016:
|
|
September
30, 2017
|
|
December
31, 2016
|
Costs
and estimated earnings in excess of billings on uncompleted
contracts
|
|
$
|
108,377,905
|
|
|
$
|
99,578,526
|
|
Billings
in excess of costs and estimated earnings on uncompleted
contracts
|
|
|
(413,004
|
)
|
|
|
(115,337
|
)
|
Totals
|
|
$
|
107,964,901
|
|
|
$
|
99,463,189
|
|
U.S.
Government contracts includes contracts directly with the U.S. Government and Government subcontracts.
NOTES
TO CONDENSED FINANCIAL STATEMENTS
(UNAUDITED)
Revisions
in the estimated gross profits on contracts and contract amounts are made in the period in which the circumstances requiring the
revisions occur. During the nine months ended September 30, 2017, the effect of such revisions in total estimated contract profits
resulted in a decrease to the total gross profit to be earned on the contracts of approximately $1,684,000 from that which would
have been reported had the revised estimates been used as the basis of recognition of contract profits in prior years, excluding
the effect of the A-10 contract. During the nine months ended September 30, 2016, the effect of such revisions was a decrease
to total gross profit of approximately $1,627,000.
Although
management believes it has established adequate procedures for estimating costs to uncompleted open contracts, it is possible
that additional significant costs could occur on contracts prior to completion.
|
5.
|
income
(Loss) PER COMMON SHARE
|
Basic
income (loss) per common share is computed using the weighted average number of common shares outstanding. Diluted income
(loss) per common share for the three and nine month periods ended September 30, 2017 and 2016 is computed using the weighted
average number of common shares outstanding adjusted for the incremental shares attributed to outstanding options to purchase
common stock, as well as unvested RSUs. Incremental shares of 74,168 were used in the calculation of diluted income per
common share in the three and nine months ended September 30, 2017. Incremental shares of 89,466 were not used in the
calculation of diluted income per common share in the three and nine month periods ended September 30, 2017, as their
exercise price was in excess of the Company’s average stock price for the respective period and, accordingly, these
shares are not assumed to be exercised for the diluted earnings per share calculation, as they would be anti-dilutive.
Incremental shares of 48,469 were used in the calculation of diluted income per common share in the three months ended
September 30, 2016. Incremental shares of 179,983 were not used in the calculation of diluted income per common share in the
three month period ended September 30, 2016, as their exercise price was in excess of the Company’s average stock price
for the respective period and, accordingly, these shares are not assumed to be exercised for the diluted earnings per share
calculation, as they would be anti-dilutive. No incremental shares were used in the calculation of diluted income per common
share in the nine month period ended September 30, 2016, as the effect of incremental shares would be
anti-dilutive.
On
December 5, 2012, the Company entered into an Amended and Restated Credit Agreement (“Restated Agreement”) with Sovereign
Bank, now called Santander Bank, N.A. (“Santander”), as the sole arranger, administrative agent and collateral agent,
and Valley National Bank. The Restated Agreement provided for a revolving credit loan (“Revolving Facility”) commitment
of $35 million and was terminated in March 2016.
On
March 24, 2016, the Company entered into a Credit Agreement with Bank United, N.A. as the sole arranger, administrative
agent and collateral agent and Citzens Bank N.A. (the “BankUnited Facility”). The BankUnited Facility provides
for a revolving credit loan commitment of $30 million (the “Revolving Loan”) and a $10 million term loan
(“Term Loan”). The proceeds of the BankUnited Facility were used to pay off all amounts outstanding under
the Santander Term Facility and the Revolving Facility. The Revolving Loan bears interest at a rate based upon a
pricing grid, as defined in the agreement. The term of the BankUnited Facility is through March 23, 2019.
On
May 9, 2016, the Company entered into an amendment (the “Amendment”) to the BankUnited Facility. The Amendment changed
the definition of EBITDA for the Leverage Coverage Ratio Covenant for the remainder of 2016 and changed the maximum leverage ratio
from 3 to 1 to 3.5 to 1 for the quarters ended June 30, 2016 and September 30, 2016. Also, the Amendment increased the interest
rate on the BankUnited Facility by 50 basis points and requires the repayment of a portion of the Term Loan if and to the extent
that the Company receives any contract reimbursement payments from its current Request for Equitable Adjustment with Boeing on
the A-10 program
.
As
of September 30, 2017, the Company was in compliance with all of the financial covenants contained in the BankUnited Facility,
as amended.
As
of September 30, 2017, the Company had $23.4 million outstanding under the Revolving Loan bearing interest at 4.75%.
The
BankUnited Facility is secured by all of the Company’s assets.
NOTES
TO CONDENSED FINANCIAL STATEMENTS
(UNAUDITED)
7.
LONG-TERM
DEBT
On
March 9, 2012, the Company obtained a $4.5 million term loan from Santander to be amortized over five years (the “Santander
Term Facility”). The Santander Term Facility was used to purchase tooling and equipment for new programs.
Additionally,
the Company and Santander entered into a five year interest rate swap agreement, in the notional amount of $4.5 million.
Under the interest rate swap, the Company paid an amount to Santander representing interest on the notional amount at a fixed
rate of 4.11% and received an amount from Santander representing interest on the notional amount of a rate equal to the one-month
LIBOR plus 3%. The effect of this interest rate swap was the Company paying a fixed interest rate of 4.11% over the term of the
Santander Term Facility.
The
Santander interest swap agreement was terminated and the Santander Term Facility was paid off on March 24, 2016 using the proceeds
of the BankUnited Facility (see Note 6).
In
May 2016, the Company entered into a new interest rate swap with the objective of reducing its exposure to cash flow volatility
arising from interest rate fluctuations associated with certain debt. The notional amount, maturity date and currency of this
contract match those of the underlying debt. The Company has designated this interest rate swap contract as a cash flow hedge.
The
Company paid approximately $254,000 of debt issuance costs in connection with the BankUnited Facility of which approximately $96,000
is included in other current assets and $32,000 is a reduction of long-term debt.
The
Term Loan had an initial amount of $10 million, payable in monthly installments, as defined in the agreement, which matures on
March 31, 2019.
The
maturities of long-term debt (excluding unamortized debt issuance costs) are as follows:
Twelve
months ending September 30,
|
|
|
2018
|
|
$
|
1,863,711
|
|
2019
|
|
|
7,314,398
|
|
2020
|
|
|
124,273
|
|
2021
|
|
|
27,354
|
|
Thereafter
|
|
|
—
|
|
|
|
$
|
9,329,736
|
|
In
addition to the Term Loan, included in long-term debt are capital leases and notes payable of $454,737, including a current portion
of $155,377.
8.
MAJOR
CUSTOMERS
During
the nine months ended September 30, 2017, the Company’s four largest commercial customers accounted for 28%, 23%, 11% and
10% of revenue. During the nine months ended September 30, 2016, the Company’s three largest commercial customers
accounted for 35%, 30% and 13% of revenue. In addition, during the nine months ended September 30, 2017, 5.2% of
revenue was directly from the U.S. Government.
At
September 30, 2017, 32%, 23%, 11% and 10% of costs and estimated earnings in excess of billings on uncompleted contracts were
from the Company’s four largest commercial customers. At December 31, 2016, 33%, 26%, 12% and 11% of costs and estimated
earnings in excess of billings on uncompleted contracts were from the Company’s four largest commercial customers.
At
September 30, 2017 and December 31, 2016, 2% and 1%, respectively, of costs and estimated earnings in excess of billings on uncompleted
contracts were directly from the U.S. Government.
At
September 30, 2017, 20%, 19%, 19%, 12% and 11% of our accounts receivable were from our five largest commercial customers.
At December 31, 2016, 35%, 24% and 17% of accounts receivable were from our three largest commercial customers.
Item
2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations
The
following discussion should be read in conjunction with the Company’s Condensed Financial Statements and notes thereto contained
in this report.
Forward
Looking Statements
When
used in this Form 10-Q and in future filings by us with the Securities and Exchange Commission,
the words or phrases “will likely result,” “management expects”
or “we expect,” “will continue,” “is anticipated,”
“estimated” or similar expressions are intended to identify “forward-looking
statements” within the meaning of the Private Securities Litigation Reform Act
of 1995. Readers are cautioned not to place undue reliance on any such forward-looking
statements, each of which speaks only as of the date made. Such statements are subject
to certain risks and uncertainties that could cause actual results to differ materially
from historical earnings and those presently anticipated or projected. The risks are
included in Item 1A - Risk Factors of our Annual Report on Form 10-K for the year ended
December 31, 2016 and Item 2 - Management’s Discussion and Analysis of Financial
Condition and Results of Operations included in this Form 10-Q. We have no obligation
to publicly release the result of any revisions which may be made to any forward-looking
statements to reflect anticipated or unanticipated events or circumstances occurring
after the date of such statements.
Business
Operations
We
are a manufacturer of structural aircraft parts for fixed wing aircraft and helicopters in both the commercial and defense markets.
Within the global aerostructure supply chain, we are either a Tier 1 supplier to aircraft Original Equipment Manufacturers (“OEMs”)
or a Tier 2 subcontractor to major Tier 1 manufacturers. We also are a prime contractor to the U.S. Department of Defense, primarily
the Air Force. In conjunction with our assembly operations, we provide engineering, program management, supply chain management,
and Maintenance Repair & Overhaul (“MRO”) services.
Item
2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations
Backlog
We
produce custom assemblies pursuant to long-term contracts and customer purchase orders. Backlog consists of aggregate values under
such contracts and purchase orders, excluding the portion previously included in operating revenues on the basis of percentage
of completion accounting, and including estimates of future contract price escalation. Substantially all of our backlog is subject
to termination at will and rescheduling, without significant penalty. Funds are often appropriated for programs or contracts on
a yearly or quarterly basis, even though the contract may call for performance that is expected to take a number of years. Therefore,
our funded backlog does not include the full value of our contracts. Our total backlog as of September 30, 2017 and December 31,
2016 was as follows:
Backlog
(Total)
|
|
September
30,
2017
|
|
December
31,
2016
|
Funded
|
|
$
|
100,583,000
|
|
|
$
|
94,540,000
|
|
Unfunded
|
|
|
297,309,000
|
|
|
|
321,744,000
|
|
Total
|
|
$
|
397,892,000
|
|
|
$
|
416,284,000
|
|
Approximately
79% of the total amount of our backlog at September 30, 2017 was attributable to government contracts. Our backlog attributable
to government contracts at September 30, 2017 and December 31, 2016 was as follows:
Backlog
(Government)
|
|
September
30,
2017
|
|
December
31,
2016
|
Funded
|
|
$
|
94,609,000
|
|
|
$
|
92,189,000
|
|
Unfunded
|
|
|
218,682,000
|
|
|
|
229,543,000
|
|
Total
|
|
$
|
313,291,000
|
|
|
$
|
321,732,000
|
|
Our
backlog attributable to commercial contracts at September 30, 2017 and December 31, 2016 was as follows:
Backlog
(Commercial)
|
|
September
30,
2017
|
|
December
31,
2016
|
Funded
|
|
$
|
5,974,000
|
|
|
$
|
2,351,000
|
|
Unfunded
|
|
|
78,627,000
|
|
|
|
92,201,000
|
|
Total
|
|
$
|
84,601,000
|
|
|
$
|
94,552,000
|
|
Our
unfunded backlog is primarily comprised of the long-term contracts for the G650, E-2D, F-16, T-38, F-35, HondaJet Light Business
Jet, Bell AH-1Z, Cessna Citation X+, Sikorsky S-92 and Embraer Phenom 300. These long-term contracts are expected to have yearly
orders, which will be funded in the future.
The
low level of funded backlog on commercial programs is the result of customers placing funded orders based upon expected lead time.
These programs are under long-term agreements with our customers, and as such, we are protected by termination liability provisions.
Item
2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations
Critical
Accounting Policies
Revenue
Recognition
We
recognize revenue from our contracts over the contractual period under the percentage-of-completion (“POC”) method
of accounting. Under the POC method of accounting, sales and gross profit are recognized as work is performed based on the relationship
between actual costs incurred and total estimated costs at the completion of the contract. Recognized revenues that will not be
billed under the terms of the contract until a later date are recorded as an asset captioned “Costs and estimated earnings
in excess of billings on uncompleted contracts.” Contracts where billings to date have exceeded recognized revenues are
recorded as a liability captioned “Billings in excess of costs and estimated earnings on uncompleted contracts.” Changes
to the original estimates may be required during the life of the contract. Estimates are reviewed monthly and the effect of any
change in the estimated gross margin percentage for a contract is reflected in cost of sales in the period the change becomes
known. The use of the POC method of accounting involves considerable use of estimates in determining revenues, costs and profits
and in assigning the amounts to accounting periods. As a result, there can be a significant disparity between earnings (both for
accounting and tax purposes) as reported and actual cash received by us during any reporting period. We continually evaluate all
of the issues related to the assumptions, risks and uncertainties inherent with the application of the POC method of accounting;
however, we cannot assure you that our estimates will be accurate. If our estimates are not accurate or a contract is terminated,
we will be forced to adjust revenue in later periods. Furthermore, even if our estimates are accurate, we may have a shortfall
in our cash flow and we may need to borrow money, or seek access to other forms of liquidity, to fund our work in process or to
pay taxes until the reported earnings materialize as actual cash receipts.
When
adjustments are required for the estimated total revenue on a contract, these changes are recognized with an inception-to-date
effect in the current period. Also, when estimates of total costs to be incurred exceed estimates of total revenue to be earned,
a provision for the entire loss on the contract is recorded in the period in which the loss is determined.
Item 2
– Management’s Discussion and Analysis of Financial Condition and Results of Operations
Results
of Operations
Revenue
Revenue
for the three months ended September 30, 2017 was $20,706,460 compared to $22,110,829 for the same period last year, a decrease
of $1,404,369 or 6.4%. This decrease is predominantly the result of a normal cyclical decrease in revenue on the Company’s
E-2D program.
Revenue
for the nine months ended September 30, 2017 was $57,471,112 compared to $57,061,826 for the same period last year, an increase
of $409,286 or 0.7%.
During
the three months ended March 31, 2016, the Company had information that the United States Air Force ("USAF") was intending
to increase the number of ship sets on order for the A-10. An increase in the number of ship sets on order would improve the Company’s
estimated gross margin on the overall program.
In
April 2016, the Company became aware that the USAF had reevaluated its position and as such had deferred any decision regarding
increasing the orders on the A-10 program. These changes in position by the USAF were supported by communications from Boeing,
the Company’s customer.
Based
on the above facts, the Company believed that it was not probable that there would be any future orders on the A-10 beyond
the 173 currently on order. As a result of the information that management became aware of in April 2016, for the quarter
ended March 31, 2016 the Company estimated that the A-10 program would run through the conclusion of its current purchase
order with Boeing at ship set number 173. The change in estimate resulted in a reduction of revenue of approximately $8.9
million in the quarter ended March 31, 2016.
In
addition to the change in estimate adjustment to revenue in the quarter ended March 31, 2016, which caused military revenue to
be unusually low in that year, military revenue in 2017 increased by approximately $10.0 million.
Revenue
from commercial subcontracts was $21,485,354 for the nine months ended September 30, 2017 compared to $31,170,895 for the nine
months ended September 30, 2016, a decrease of $9,685,541 or 31.1%. The decrease in revenue is the result of an approximate $4.9
million decrease in revenue on our Embraer Phenom 300 program, as production rates have declined and a $3.8 million decrease in
revenue on our G650 program.
Inflation
historically has not had a material effect on our operations.
Cost
of sales
Cost
of sales for the three months ended September 30, 2017 and 2016 was $15,794,024 and $17,086,461, respectively, a decrease of $1,292,437
or 7.6%, This decrease is the result of the comparable decline in revenue.
Cost
of sales for the nine months ended September 30, 2017 and 2016 was $44,337,414 and $58,642,561, respectively, a decrease of $14,305,147
or 24.4%. The provision for contract losses, as well as lower rate production on our E-2D, Phenom 300 and Embraer programs, all
described above, have resulted in lower cost of sales.
Item
2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations
The
components of the cost of sales were as follows:
|
|
Three
months ended
|
|
Nine
months ended
|
|
|
September
30, 2017
|
|
September
30, 2016
|
|
September
30, 2017
|
|
September
30, 2016
|
Procurement
|
|
$
|
10,709,002
|
|
|
$
|
12,767,192
|
|
|
$
|
28,613,115
|
|
|
$
|
39,000,097
|
|
Labor
|
|
|
1,666,176
|
|
|
|
1,950,312
|
|
|
|
5,252,745
|
|
|
|
6,280,722
|
|
Factory
overhead
|
|
|
3,616,974
|
|
|
|
3,996,607
|
|
|
|
11,404,680
|
|
|
|
11,984,948
|
|
Other
contract costs
|
|
|
(198,128
|
)
|
|
|
(1,627,650
|
)
|
|
|
(933,126
|
)
|
|
|
1,376,794
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost
of Sales
|
|
$
|
15,794,024
|
|
|
$
|
17,086,461
|
|
|
$
|
44,337,414
|
|
|
$
|
58,642,561
|
|
Other
contract costs (credit) for the nine months ended September 30, 2017 were $(933,126) compared to $1,376,794, a decrease of $2,309,920.
Other contract costs (credit) for the three months ended September 30, 2017 were $(198,128) compared to $(1,627,650), an increase
of $1,429,522. Other contract costs relate to expenses recognized for changes in estimates and expenses predominately associated
with loss contracts. Other contract costs are comprised predominantly of charges related to the change in estimate on the A-10
program in 2016. In the nine months ended September 30, 2017, other contract costs are a credit, as we have incurred actual expenses
on our A-10 program that had been previously recognized as part of the change in estimate charge.
Procurement
for the nine months ended September 30, 2017 was $28,613,115 compared to $39,000,097, a decrease of $10,386,982 or 26.6%. Procurement
for the three months ended September 30, 2017 was $10,709,002 compared to $12,767,192, a decrease of $2,058,190 or 16.1%. This
decrease is a result of a $5.0 million decrease in procurement on our E-2D program, as we are shipping parts from stock and lowering
inventory on this program, as well as an approximately $5.8 million decrease in procurement on the commercial programs described
above.
Labor
costs for the nine months ended September 30, 2017 were $5,252,745 compared to $6,280,722, a decrease of $1,027,977 or
16.4%. The decrease is the result of an approximate $322,000 decrease in the commercial programs described above, as well
as a $705,000 decrease in military programs. Labor costs for the three months ended September 30, 2017 were $1,666,176
compared to $1,950,312, a decrease of $284,135 or 14.6%.
Factory
overhead for the nine months ended September 30, 2017 was $11,404,680 compared to $11,984,948, a decrease of $580,268 or 4.8%.
Factory overhead for the three months ended September 30, 2017 was $3,616,974 compared to $3,996,607, a decrease of $379,633 or
9.5%.
Gross
Profit (Loss)
Gross
profit (loss) for the nine months ended September 30, 2017 was a profit of $13,133,698 compared to a loss of $1,580,735 for the
nine months ended September 30, 2016, an increase of $14,714,433, predominately the result of the change in estimate on the A-10
program.
Gross
profit for the three months ended September 30, 2017 was $4,912,436 compared to $5,024,368 for the three months ended September
30, 2016, a decrease of $111,932 predominately the result of lower volume, as described above.
Item 2
– Management’s Discussion and Analysis of Financial Condition and Results of Operations
Favorable/Unfavorable
Adjustments to Gross Profit (Loss)
During
the nine months ended September 30, 2017 and 2016, circumstances required that we make changes in estimates to various contracts.
Such changes in estimates resulted in decreases in total gross profit as follows:
|
|
Nine
months ended
|
|
|
September
30,
2017
|
|
September
30,
2016
|
Favorable
adjustments
|
|
$
|
381,000
|
|
|
$
|
235,000
|
|
Unfavorable
adjustments
|
|
|
(2,065.000
|
)
|
|
|
(1,862,000
|
)
|
Net
adjustments
|
|
$
|
(1,684,000
|
)
|
|
$
|
(1,627,000
|
)
|
During
the nine months ended September 30, 2017, we had three contracts which had approximately $910,000, $506,000 and $436,000 of
unfavorable adjustments caused by changing estimates on a long-term program; we are working with the customer to agree to
contract extensions and expect to have to decrease our selling price. Additionally, we had one contract that had a gap in production,
as well as a smaller than expected order quantity. The gap in production and low quantity has resulted in an unfavorable adjustment
of approximately $508,000. There were no other material changes favorable or unfavorable during the nine months ended September
30, 2017.
During
the nine months ended September 30, 2016, we had one contract which had approximately $270,000 of an unfavorable adjustment
caused by excess labor and procurement costs due to difficulty in the manufacturing process. In addition, we had an
approximate $354,000 unfavorable adjustment on one contract that was canceled by the government. Also, we had four contracts
that each had between $140,000 and $245,000 (cumulatively $890,000) of unfavorable adjustments caused by excess labor costs
incurred. No other individual favorable or unfavorable changes in estimates for the nine months ended September 30, 2016 were
material.
In
addition to the above mentioned unfavorable adjustments, in 2016 we had the unfavorable adjustment of approximately $13.5 million
related to the A-10 program described previously.
Selling,
General and Administrative Expenses
Selling,
general and administrative expenses for the three months ended September 30, 2017 were $2,044,304 compared to $2,014,147 for the
three months ended September 30, 2016, an increase of $30,157 or 1.5%. This change was predominately the result of an increase
of $150,000 in accrued bonuses and an increase of $150,000 in bad debt expense, offset by a decrease of approximately $147,000
in professional fees, a decrease of $90,000 in salaries and a decrease of $56,000 in marketing.
Selling,
general and administrative expenses for the nine months ended September 30, 2017 were $6,210,380 compared to $6,603,321 for the
nine months ended September 30, 2016, a decrease of $392,941 or 6.0%. This decrease was predominately the result of an approximately
$456,000 decrease in professional fees because of the extended audit CPI had in 2016 and an approximately $246,000 decrease in
loss on unrealized receivables, offset by an increase in salaries of $83,000 and an increase in accrued bonuses of $300,000.
Income
(Loss) Before Provision for (Benefit from) Income Taxes
Income
before provision for income taxes for the three months ended September 30, 2017 was $2,465,513 compared to $2,672,065 for the
same period last year, a decrease of $206,552. Income before provision for income taxes for the nine months ended September 30,
2017 was $5,664,461 compared to loss before benefit from income taxes of $9,121,579 for the same period last year, an increase
of $14,786,040, predominately the result of the change in estimate on the A-10 program.
Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations
Provision
for (Benefit from) Income Taxes
Provision
for income taxes was $770,000 and $1,954,000 for the three and nine months ended September 30, 2017, compared to provision for
income taxes of $986,000 for the three months ended September 30, 2016 and a benefit from income taxes of $3,378,000 for the nine
months ended September 30, 2016. The effective tax rate at September 30, 2017 was 35%. The benefit from income taxes recognized
in the nine months ended September 30, 2016, resulted in the booking of a deferred tax asset. At December 31, 2016, the Company
had net operating loss carryforwards of approximately $14.6 million which will expire in 2031. Our historical tax rates have been
below the federal statutory rate because of the effect of permanent differences between book and tax deductions, predominately
the R&D tax credit and the domestic production activity deduction.
Net
Income (Loss)
Net
income for the three months ended September 30, 2017 was $1,695,513 or $0.19 per basic share, compared to $1,686,065 or
$0.19 per basic share for the same period last year. Net income for the nine months ended September 30, 2017 was $3,710,461
or $0.42 per basic share, compared to a loss of $5,743,579 or $0.67 per basic share for the same period last year. Diluted
income per share was $0.19 for the three months ended September 30, 2017 calculated utilizing 8,872,810 weighted average
shares outstanding. Diluted income per share for the nine months ended September 30, 2017 was $0.42, calculated utilizing
8,841,397 average shares outstanding as adjusted for the dilutive effect of outstanding stock options and RSUs. Diluted
income per share for the three months ended September 30, 2016 was $0.19, calculated utilizing 8,692,420 average shares
outstanding as adjusted for the dilutive effect of outstanding stock options and RSUs. Basic and diluted income per share for
the nine months ended September 30, 2016 were the same as effects of outstanding options would be anti-dilutive.
Liquidity
and Capital Resources
General
At
September 30, 2017, we had working capital of $75,782,789 compared to $70,595,485 at December 31, 2016, an increase of $5,187,304
or 7.3%.
Cash
Flow
A
large portion of our cash flow is used to pay for materials and processing costs associated with contracts that are in process
and which do not provide for progress payments. Costs for which we are not able to bill on a progress basis are components of
“Costs and estimated earnings in excess of billings on uncompleted contracts” on our condensed balance sheets and
represent the aggregate costs and related earnings for uncompleted contracts for which the customer has not yet been billed. These
costs and earnings are recovered upon shipment of products and presentation of billings in accordance with contract terms.
Because
the POC method of accounting requires us to use estimates in determining revenue, costs and profits and in assigning the amounts
to accounting periods, there can be a significant disparity between earnings (both for accounting and tax purposes) as reported
and actual cash that we receive during any reporting period. Accordingly, it is possible that we may have a shortfall in our cash
flow and may need to borrow money, or to raise additional capital, until the reported earnings materialize into actual cash receipts.
At
September 30, 2017, we had a cash balance of $711,083 compared to $1,039,586 at December 31, 2016.
Our
costs and estimated earnings in excess of billings increased by approximately $8.8 million during the nine months ended September
30, 2017.
Several
of our programs require us to expend up-front costs that may have to be amortized over a portion of production units. In
the case of significant program delays and/or program cancellations, we could be required to bear impairment charges, which may
be material, for costs that are not recoverable. Such charges and the loss of up-front costs could have a material
impact on our liquidity.
We
continue to work to obtain better payment terms with our customers, including accelerated progress payment arrangements, as well
as exploring alternative funding sources.
We
believe that our existing resources, together with the availability under our credit facility, will be sufficient to meet our
current working capital needs for at least 12 months from the date of the filing of our Form 10-Q.
Item
2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations
Credit
Facilities
Credit
Agreement and Term Loan
On
March 24, 2016, the Company entered into a Credit Agreement with Bank United, N.A. as the sole arranger, administrative agent
and collateral agent and Citzens Bank, N.A. (the “BankUnited Facility”). The BankUnited Facility provides for a revolving
credit loan commitment of $30 million (the “Revolving Loan”) and a $10 million term loan (“Term Loan”).
The proceeds of the BankUnited Facility were used to pay off all amounts outstanding under the Santander Term Loan and the Revolving
Facility. The Revolving Loan bears interest at a rate based upon a pricing grid, as defined in the agreement.
As
of March 31, 2016, the Company was not in compliance with the net profit, Debt Service Coverage, and Leverage Coverage Ratio financial
covenants contained in the BankUnited Facility, which non-compliance was waived (the “Waiver”) by the banks. On May
9, 2016 the Company entered into an amendment (the “Amendment”) to the BankUnited Facility which, among other things,
provided for the Waiver. In addition, the Amendment changes the definition of EBITDA for the Leverage Coverage Ratio Covenant
for the remainder of 2016 and changes the maximum leverage ratio from 3 to 1 to 3.5 to 1 for the quarters ended June 30, 2016
and September 30, 2016. Also, the Amendment increased the interest rate on the BankUnited Facility by 50 basis points and requires
the repayment of a portion of the Term Loan if and to the extent that the Company receives any contract reimbursement payments
from its current Request for Equitable Adjustment with Boeing on the A-10 program.
As
of September 30, 2017, the Company had $23.4 million outstanding under the Revolving Loan bearing interest at 4.75%.
The
BankUnited Revolving Facility is secured by all of our assets.
The
Term Loan had an initial amount of $10 million, payable in monthly installments, as defined in the agreement, which matures on
March 31, 2019. The maturities of the Term Loan are included in the maturities of long-term debt.
On
March 9, 2012, the Company obtained a $4.5 million term loan from Santander to be amortized over five years (the “Santander
Term Facility”). Santander Term Facility was used to purchase tooling and equipment for new programs.
Additionally,
the Company and Santander entered into a five year interest rate swap agreement, in the notional amount of $4.5
million. Under the interest rate swap, the Company paid an amount to Santander representing interest on the notional amount
at a fixed rate of 4.11% and received an amount from Santander representing interest on the notional amount of a rate equal
to the one-month LIBOR plus 3%. The effect of this interest rate swap was the Company paying a fixed interest rate of 4.11%
over the term of the Santander Term Facility.
The
Santander interest swap agreement was terminated and the Santander Term Facility paid off on March 24, 2016 using the proceeds
of the BankUnited Facility.
In
May 2016, the Company entered into a new interest rate swap with the objective of reducing its exposure to cash flow volatility
arising from interest rate fluctuations associated with certain debt. The notional amount, maturity date, and currency of this
contract match those of the underlying debt. The Company has designated this interest rate swap contract as a cash flow hedge.
Contractual
Obligations
For
information concerning our contractual obligations, see “
Contractual Obligations
” under “Item 7. Management’s
Discussion and Analysis of Financial Condition and Results of Operations” of our Annual Report on Form 10-K for the year
ended December 31, 2016.
Item
3 – Quantitative and Qualitative Disclosures About Market Risk
Management
does not believe that there is any material market risk exposure with respect to derivative or other financial instruments that
would require disclosure under this item.
Item
4 – Controls and Procedures
Evaluation
of Disclosure Controls and Procedures
The
Company’s management has established disclosure controls and procedures designed to ensure that information it is required
to disclose in the reports that it files or submits under the Securities Exchange Act of 1934, as amended (the “Exchange
Act”) is recorded, processed, summarized and reported within time periods specified in the Securities and Exchange Commission
rules and forms. Such disclosure controls and procedures include, without limitation, controls and procedures designed to ensure
that information the Company is required to disclose in the reports that it files or submits under the Exchange Act is accumulated
and communicated to the Company’s management to allow timely decisions regarding required disclosure.
Based
on an evaluation of the Company’s disclosure controls and procedures as of September 30, 2017 made by management, under
the supervision and with the participation of the Chief Executive Officer and Chief Financial Officer, the Chief Executive Officer
and Chief Financial Officer have concluded that the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e)
and 15d-15(e) promulgated under the Exchange Act) were effective as of September 30, 2017.
Changes
in Internal Control Over Financial Reporting
There
has been no change in our internal control over financial reporting during the quarter ended September 30, 2017 that has materially
affected or is reasonably likely to materially affect our internal control over financial reporting.
Part
II: Other Information
Item
1 – Legal Proceedings
None.
Item
1A – Risk Factors
Material
risks related to our business, financial condition and results of operations are disclosed in Part I, Item 1A of our Annual Report
on Form 10-K for the year ended December 31, 2016, as filed with the SEC on March 8, 2017. There have been no material changes
to such risk factors. The risk factors disclosed in our Annual Report should be carefully considered in evaluating
our business because such factors may have a significant impact on our business, operating results, liquidity and financial condition.
Changes
in accounting standards could affect our reported financial results.
New
accounting standards or pronouncements that may become applicable to our Company from time to time, or changes in the interpretation
of existing standards and pronouncements, could have a significant effect on our reported financial results for the affected periods.
Item
2 – Unregistered Sales of Equity Securities and Use of Proceeds
There
have been no sales of unregistered equity securities for the nine months ended September 30, 2017.
Item
3 – Defaults Upon Senior Securities
None.
Item
4 – Mine Safety Disclosures
Not
applicable.
Item
5 – Other Information
None.
Item
6 – Exhibits
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned thereunto duly authorized.
|
|
CPI
AEROSTRUCTURES, INC.
|
|
|
|
|
|
|
|
|
|
Dated:
November 9, 2017
|
By.
|
/s/
Douglas J. McCrosson
|
|
|
Douglas
J. McCrosson
|
|
|
Chief
Executive Officer and President
|
|
|
|
|
|
|
|
|
|
Dated:
November 9, 2017
|
By.
|
/s/
Vincent Palazzolo
|
|
|
Vincent
Palazzolo
|
|
|
Chief
Financial Officer (Principal Accounting Officer)
|